TILRAY BRANDS, INC. and HEXO CORP. and COMPUTERSHARE TRUST COMPANY OF CANADA THIRD SUPPLEMENTAL WARRANT INDENTURE Supplementing the Warrant Indenture Dated as of June 25, 2020 June 22, 2023Third Supplemental Warrant Indenture • June 22nd, 2023 • Tilray Brands, Inc. • Medicinal chemicals & botanical products • British Columbia
WHEREAS Zenabis Global Inc. (“Zenabis”) entered into a warrant indenture dated as of June 25, 2020 (as amended by the First Supplemental Indenture and Second Supplemental Indenture, the “Indenture”) with the Warrant Agent providing for the issue of up to 181,290,456 common share purchase warrants (the “Zenabis Warrants”) with each whole Zenabis Warrant exercisable to acquire one common share of Zenabis (each, a “Zenabis Share”) at an exercise price of C$0.16 per Zenabis Share at any time prior to 5:00 p.m. (Toronto time) on June 25, 2025;
THIS THIRD SUPPLEMENTAL WARRANT INDENTURE is made as of the 31st day of March, 2023. BETWEEN: VERSES AI INC., a company incorporated under the laws of the Province of British Columbia (the “Company”) AND:Third Supplemental Warrant Indenture • September 20th, 2024 • Verses AI Inc. • Services-computer programming, data processing, etc.
ENDEAVOR TRUST CORPORATION, a Trust Company authorized in British Columbia, Alberta, Manitoba and Saskatchewan and incorporated under the laws of the Province of British Columbia
THIRD SUPPLEMENTAL WARRANT INDENTUREThird Supplemental Warrant Indenture • September 9th, 2011 • Golden Minerals Co • Gold and silver ores • Ontario
WHEREAS on February 20, 2009, ECU entered into a warrant indenture as amended and supplemented on March 26, 2009 and May 8, 2009 (collectively, the “Indenture”), with the Warrant Agent pursuant to which ECU may issue up to 40,388,576 warrants to purchase common shares in the capital of ECU (“ECU Common Shares”) at a price of $0.95 per ECU Common Share until 5:00 p.m. (Toronto time) on February 20, 2014 (the “Warrants”);
THIRD SUPPLEMENTAL WARRANT INDENTUREThird Supplemental Warrant Indenture • September 28th, 2022
, with regard to our sale, for such Seller’s account, of the securities of [Aris Holdings/the Corporation] described therein, and on behalf of ourselves we certify and affirm that (A) we have no knowledge that the transaction had been prearranged with a buyer in the United States, (B) the transaction was executed on or through the facilities of designated offshore securities market, (C) neither we, nor any person acting on our behalf, engaged in any directed selling efforts in connection with the offer and sale of such securities, and (D) no selling concession, fee or other remuneration is being paid to us in connection with this offer and sale other than the usual and customary broker’s commission that would be received by a person executing such transaction as agent. Terms used herein have the meanings given to them by Regulation S under the U.S. Securities Act.
